Lopinavir Not Yet Recruiting Phase 2 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

Indications	Status	Purpose	Phase
DBCOND0129755 (Coronavirus Disease 2019 (COVID‑19))	Not Yet Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT04521400	the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19	Interferon beta-1a (DB00060) Lopinavir (DB01601) Ritonavir (DB00503)